baber/WOPTO huggingface dataset:
Patent AU-2016202361-A1 (AU)
Title: A gaming system, a game controller and a method of gaming
Inventor: LIU LIN
IPC: A63F13/00
Filed: 2016-04-14
Abstract: Abstract A gaming system comprising: a credit meter storing a balance of wagerable credits; a points meter storing a 5 balance of usable points; a game play mechanism operable by the player to input a play instruction for a game comprising a credit portion and a points portion; and a game controller arranged to control conduct of the game in response to the play instruction based on the credit 10 portion and the points portion and to determine whether to make an award of credits based on an outcome of the game. 7635694_1 (GHMatters) P81473.AU.3 co r) m coI m L. (9~(D C)L U, a) < IC)E0 L ZZJ o0 LOI <
Patent AU-2016206404-A1 (AU)
Title: Washing and/or drying appliance
Inventor: VIAN ALESSANDRO
IPC: D06F39/12
Filed: 2016-07-22
Abstract: P-61371/EP Abstract The invention relates to a washing and/or drying appliance, comprising - A casing including a first and second side walls, a front wall and a rear wall, said rear wall including a lower edge, and a basement defining a basement plane and supporting said rear wall, - A washing and/or drying chamber apt to contain the laundry to be washed and/or dried, said chamber being located within said casing, - Wherein one of said basement and said rear wall includes a pivot and the other of said basement and said rear wall includes a seat housing said pivot, said pivot defining an axis of rotation for said rear wall substantially perpendicular to said basement plane, so that said rear wall is apt to swing around said axis of rotation from a first semi-assembled position where it is connected to said basement substantially only by said pivot to a second assembled position where said lower edge is facing said basement. 2e 2c 2 R~ ~ ti,) ~~'K'FIG. 1 x
Patent AU-2016206974-A1 (AU)
Title: Spatial separation of particles in a particle containing solution for biomedical sensing and detection
Inventor: ZENG HANSONG
IPC: B01L3/00
Filed: 2016-01-11
Abstract: A device and method for analyte detection and analytes in a particulate bearing fluid such as whole blood having an instrument for partitioning the particles from the fluid that is integrated with a detector for analyses of one or more particulate bearing fluid analytes while the particles in the particulate bearing fluid are partitioned.
Patent AU-2016213761-A1 (AU)
Title: Method and Apparatus For Modernizing an Elevator Installation
Inventor: FRIEDLI PAUL
IPC: B66B1/18
Filed: 2016-08-10
Abstract: Abstract The invention relates to a method of modernizing a elevator installation for serving at least one floor (20, 20', 20") in at least one building, which elevator installation comprises at 5 least one elevator (A, B, C) with at least one elevator car (11, 11', 11") and at least one elevator control (5, 5', 5"). An elevator car (11, 11', 11") is controlled by the elevator control (5, 5', 5"). At least one destination call terminal (4, 4') for input of at least one destination call and/or for recognition of at least one identification code is installed on at least one input floor. At least one destination call signal is generated by the destination 10 call terminal (4, 4') for an input destination call and/or for a recognised identification code. At least one destination call control (6) is installed. The destination call terminal (4, 4') is, for communication of the destination call signal, connected with the destination call control (6). At least one start floor signal for a journey of the elevator car (11, 11', 11") to an input floor of the destination call terminal (4, 4') and at least one destination floor signal for a 15 journey of the elevator car (11, 11', 11") from the input floor to a destination floor associated with the destination call signal and/or the identification code are generated by the destination call control (6). The start floor signal and the destination floor signal are communicated by the destination call control (6) via the interface (5.3, 5.3', 5.3") to the elevator control (5, 5', 5"). (Fig. 4) 3 5 5 5" 15 15' 15" 9,9% 9" 20" 4, 4' 1, 11 13, 13'13" 3 "5, 53 5" 15, 15*, 15" 4,4' 4, 4' 1 11"113 1, 1Y1 14, 14% 14" 4, 4 f,8" Fig. 3 4, 4' 14, 14', 14" Fig, 4
Patent AU-2016243469-A1 (AU)
Title: Keratin treatments
Inventor: VALIA DAVID
IPC: A61K8/00
Filed: 2016-03-29
Abstract: The present disclosure relates generally to keratin treatments. More particularly, but not by way of limitation, present disclosure relates to skin, nail, hair, and eyelash treatments comprising a keratin-peptide/dendrimer composition for ameliorating a condition of a nail. The keratin-peptide can be keratin or hydrolyzed or partially hydrolyzed keratin.
Patent AU-2016264364-A1 (AU)
Title: Compositions for treating pathological calcification conditions, and methods using same
Inventor: BRADDOCK DEMETRIOS
IPC: C12N15/63
Filed: 2016-05-19
Abstract: The present invention includes compositions and methods for treating diseases or disorders associated with pathological calcification or pathological ossification. In certain embodiments, the diseases or disorders are selected from the group consisting of Generalized Arterial Calcification of Infancy (GACI), Idiopathic Infantile Arterial Calcification (IIAC), Ossification of the Posterior Longitudinal Ligament (OPLL), hypophosphatemic rickets, osteoarthritis, calcification of atherosclerotic plaques, PXE, hereditary and non-hereditary forms of osteoarthritis, ankylosing spondylitis, hardening of the arteries occurring with aging, calciphylaxis resulting from end stage renal disease and progeria.
Patent AU-2016269466-A1 (AU)
Title: Systems and methods for controlling aquatic lighting using power line communication
Inventor: LYONS GREG
IPC: H05B37/02
Filed: 2016-12-07
Abstract: In some embodiments of the disclosed subject matter, systems (100, 200) and methods for controlling aquatic lighting using power line communication. In some embodiments, the systems (100) include: a first power line modem (110) coupled to an AC power line (112) and a LAN (106); a user interface (102) configured to: receive user input specifying a lighting selection; and transmit lighting data representing the lighting selection to the first power line modem (110) via the LAN (106); and a lighting controller that receives power via the AC power line (120), comprising: a light driver circuit (126) coupled to a light source; a second power line modem (128) coupled to the AC power line (120), the second power line modem (128) receives the lighting data over the AC power line (120); and a processor (130) configured to: receive lighting data from the second power line modem (128); and cause the light driver circuit (126) to drive the light source to present the lighting selection. P252562 12095510 1 O- l - l 'rD' -00 IM D I Ch CO < z) C <w CD nCC FoD -:z D aD C 0) 0 - ' CD CD =- C 0 w121 C 0 K) o I WDC CP) CD ) 0 0 ( oD o a:) (0 1 CD (n 0 I5 = a 0 m Z C CD Cn CDI ~3~g _ _CD r\ 0 CDo I0'C CD a<I n CD C 0 -< 4- -- 1
Patent AU-2016287632-A1 (AU)
Title: Needle control and drug mixing systems for a fluid delivery device
Inventor: JOHNSON MATTHEW P
IPC: A61M5/28
Filed: 2016-06-30
Abstract: A fluid delivery device comprises a housing having a base including a bottom surface; a locking assembly including a cartridge receiver configured to receive a cartridge, the cartridge having a fluid reservoir and a septum configured to be generally perpendicular to the bottom surface when the cartridge is engaged with the cartridge receiver; and a needle assembly having a needle, the needle having a delivery end, a fluid coupling end, and a central portion located between the delivery end and the fluid coupling end, the needle assembly configured to move in laterally relative to the base to a first position and vertically relative to the base to a second position. The locking assembly prevents the needle assembly from moving to one or both of the first and second positions unless the cartridge is engaged with the cartridge receiver.
Patent AU-2016330471-A1 (AU)
Title: Antibodies that bind human cannabinoid 1 (CB1) receptor
Inventor: KRETZ-ROMMEL ANKE
IPC: G01N33/94
Filed: 2016-09-27
Abstract: The present invention relates to novel antibodies and fragments thereof that binds cannabinoid 1 (CB1) receptor. The antibodies and fragments thereof as disclosed herein include humanized antibodies that bind CB1 receptor. The invention also includes uses of the antibodies for treating a disease or disorder responsive to antagonism or agonism of the CB1 receptor.
Patent AU-2016333898-A1 (AU)
Title: Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
Inventor: JANTZ DEREK
IPC: C12N15/113
Filed: 2016-10-05
Abstract: Disclosed herein is a genetically-modified cell comprising in its genome a modified human T cell receptor alpha constant region gene, wherein the cell has reduced cell-surface expression of the endogenous T cell receptor. The present disclosure further relates to methods for producing such a genetically-modified cell, and to methods of using such a cell for treating a disease in a subject.
Patent AU-2016335287-A1 (AU)
Title: Pharmaceutical formulations for the oral delivery of peptide drugs
Inventor: FOGER FLORIAN
IPC: A61K38/04
Filed: 2016-10-07
Abstract: The present invention relates to improved pharmaceutical formulations, uses and methods for the oral delivery of peptide drugs with advantageously high bioavailability, safety and costeffectiveness. In particular, the invention provides a peptide drug having a molecular weight of equal to or less than 5 kDa for use as a medicament, wherein said peptide drug is to be administered orally in combination with a pharmaceutically acceptable copper salt/complex and/or a pharmaceutically acceptable zinc salt/complex and/or a pharmaceutically acceptable iron salt/complex, and with a pharmaceutically acceptable complexing agent. The invention also provides a pharmaceutical composition comprising: a peptide drug having a molecular weight of equal to or less than 5 kDa; a pharmaceutically acceptable copper salt/complex and/or a pharmaceutically acceptable zinc salt/complex and/or a pharmaceutically acceptable iron salt/complex; and a pharmaceutically acceptable complexing agent.
Patent AU-2016346881-A1 (AU)
Title: Surgical implant and process of manufacturing thereof
Inventor: PRIEWE JORG
IPC: A61F2/00
Filed: 2016-10-06
Abstract: A surgical implant (20) comprises a flexible, areal basic structure (22) having a first face and a second face and being provided with pores (26) extending from the first face to the second face. A barrier layer (24) having a first face and a second face is placed, with its second face, at the first face of the basic structure (2) and attached to the basic structure (22). The barrier layer (24) is deformed into at least part of the pores (26) where it forms, in a respective pore (10), a barrier region (28).
Patent AU-2016346919-A1 (AU)
Title: Interactive salt model modification
Inventor: PIXTON JOHN LINN
IPC: G06T15/00
Filed: 2016-10-21
Abstract: A method for making changes to a salt model are described. In particular, an algorithm allows a user to interactively edit a salt model to reflect migrated seismic data to improve model accuracy without having to select horizons that overlap or are sealed or decrease the resolution of the horizons. Instead, sealed horizon pairs are automatically generated from the edited data using a new algorithm.
Patent AU-2016370708-A1 (AU)
Title: Device allowing an alimentary bolus flow between two stomas
Inventor: LOGIER RÉGIS
IPC: A61M1/00
Filed: 2016-12-05
Abstract: The present invention concerns a device allowing the creation of an alimentary bolus flow between two stomas (S1; S2), comprising: - means forming a pump (14, 131); - first/second sealed connection means (1) capable of connecting said suction opening to an upstream/downstream stoma (S1; S2) located on the abdominal wall of a patient; and - first and/or second anti-reflux means (21, 3; 41, 3). According to the invention, said first and/or second anti-reflux means comprise a cavity (21; 41) into which said alimentary bolus passes, an inflatable balloon (3) mounted in said cavity and means (G) for inflating said balloon, that make it possible to modify the inflation of the latter, and said balloon (3) is shaped to shift from an open position in which said balloon (3) is partially inflated and has a neck (32) allowing the passage of the alimentary bolus, to a closed position in which said balloon (3) is more inflated than in said open position and in which said balloon is in contact with the wall of said cavity and said neck (32) is sealed as a result of the portion of the wall of said balloon defining said neck (32) being compressed against itself, at least over a portion of the height of said neck (32).
Patent AU-2016371923-A1 (AU)
Title: Pre-operative determination of implant configuration for soft-tissue balancing in orthopedic surgery
Inventor: VANHEULE VALENTINE
IPC: A61F2/30
Filed: 2016-12-14
Abstract: Certain embodiments described herein relate to systems and methods for determining implant configuration or design of implants by taking into account soft tissues and utilizing patient-specific simulations of activities of daily living.
Patent AU-2016376837-A1 (AU)
Title: Machining device
Inventor: RÖTTGEN BORIS
IPC: B23Q1/00
Filed: 2016-12-20
Abstract: The present invention relates to a machining device for machining workpieces. These workpieces can, purely by way of example, be workpieces made of wood, wood materials, plastic or the like. The machine tool comprises a machine bed (10) and a machining unit (20) which is movable along the machine bed (10) and in the housing (21) of which a machining assembly (25) is provided, and at least one sensor (30a, 30b, 30c, 30d; 40) attached to the housing (21) of the machining unit, said sensor being intended to monitor a travel movement of the machining unit (20), wherein an operating element (50a, 50b, 50c) is provided on the housing (21) of the movable machining unit in order to input an operating command, in particular a start or stop command, for the machining unit (20).
Patent WO-2018107226-A1 (WO)
Title: Méthodes de traitement de troubles oculaires
Inventor: NELMS KEATS
IPC: A61P27/02
Filed: 2017-12-13
Abstract: L'invention concerne l'utilisation d'un inhibiteur de l'héparanase pour traiter ou inhiber la progression ou le développement d'un trouble inflammatoire oculaire, tel que la dégénérescence maculaire liée à l'âge, la rétinopathie diabétique, la rétinite pigmentaire, l'occlusion de la veine de la rétine, le rétinoblastome, l'uvéite, l'oedème maculaire, l'oeil sec, l'inflammation oculaire associée à une infection ou au kératocône.
Patent AU-2017200410-A1 (AU)
Title: Operation communication system
Inventor: AHEARN JOHN ROBERT
IPC: G07C9/00
Filed: 2017-01-20
Abstract: An operation communication system is provided including a server, a mobile device, and a reader device. The server and the reader device communicate data with one another via the mobile device. The mobile device may communicates with the reader device via Bluetooth, for example. The mobile device may communicate with the server via the Internet, for example. Associated methods, devices and apparatuses are also provided.
Patent AU-2017208299-A1 (AU)
Title: Method and system for processing PIN debit transactions
Inventor: KERESMAN III MICHAEL A
IPC: G06Q20/00
Filed: 2017-07-27
Abstract: A system for processing a debit transaction between a merchant and a consumer. The system includes one or more processors programmed to receive payment information for the consumer, collect authentication data for the debit card from the consumer, transmit an alias account number unique to the debit transaction to the merchant, receive a credit authorization message including the alias account number from the merchant, translate the credit authorization message to a debit authorization message using the authentication data, and transmit the debit authorization message to a payment processor. WO 2011/127029 PCT/US201 1/031210 LuL > < (A Lu zA 2 Aa UuU gf 0 0< 0 uj HD 2 u Lu V)z CL> (N U (j 0u uL (A Hnlt L IH -i .4 --
Patent AU-2017210538-A1 (AU)
Title: Compositions and methods for mucositis and oncology therapies
Inventor: BASCOMB NEWELL
IPC: A23K20/195
Filed: 2017-08-02
Abstract: In alternative embodiments, this invention provides compositions and methods for treating cancer or any condition caused by dysfunctional cells, side effects from treatments for cancer or any condition caused by dysfunctional cells, e.g., mucositis therapies (e.g., for oral mucositis; digestive mucositis; esophageal mucositis; intestinal mucositis). In alternative embodiments, the invention provides cytoprotection products that may be used either alone or in combination with other medical therapies such as cancer chemotherapies and radiation therapies.
Patent AU-2017211954-A1 (AU)
Title: Intaglio magnetic machine readable oxidative drying inks
Inventor: KRUEGER JESSICA
IPC: C09D11/03
Filed: 2017-01-26
Abstract: The present invention relates to the field of magnetic machine readable oxidative drying suitable for intaglio printing of security documents. In particular, the invention relates to magnetic oxidative drying ink for intaglio printing on a substrate, said magnetic oxidative drying ink having a viscosity in the range of about 3 to about 60 Pa s at 40°C and 1000 s
Patent AU-2017213170-A1 (AU)
Title: AAV-based conditional expression system
Inventor: KOSZINOWSKI ULRICH
IPC: C12Q1/68
Filed: 2017-01-30
Abstract: The present invention relates to a cell comprising (aa) a nucleic acid comprising in 5' to 3' direction (i) at least one adeno-associated virus (AAV) inverted terminal repeat (ITR) sequence; (ii) a promoter which is capable of being activated by (a) helper polypeptide(s) and optionally (a) helper polynucleotide(s); and (iii) a transgenic coding sequence under the control of said promoter of (aa)(ii); and (ab) a nucleic acid comprising in 5' to 3' direction (i) a promoter which is capable of being activated by said helper polypeptide(s) and optionally said helper polynucleotide(s); and (ii) at least one AAV rep gene coding sequence under the control of said promoter of (ab)(i); wherein said cell does not comprise an AAV cap gene and/or is not able to express any AAV cap gene product.
Patent AU-2017221794-A1 (AU)
Title: Methods of Purifying Antibodies
Inventor: ELSON GREG
IPC: A61K39/00
Filed: 2017-08-30
Abstract: The invention provides methods of purifying antibodies using various antibody- specific purification media to rapidly and efficiently separate mixtures of antibodies, antibody fragments and/or antibody components to isolate a desired antibody product from the mixture. The invention relates to the purification of bispecific monoclonal antibodies carrying a different specificity for each binding site of the immunoglobulin molecule, e.g., antibodies composed of a single heavy chain and two different light chains, one containing Kappa constant domain and the other a Lambda constant domain, including antibodies of different specificities that share a common heavy chain. The invention also provides the methods of efficiently purifying intact antibodies by separating the intact antibody from non-intact antibodies including free light chains.
Patent AU-2017239524-A1 (AU)
Title: Use of anti-CGRP or anti-CGRP-R antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
Inventor: RUSSO ANDREW F
IPC: A61K31/7088
Filed: 2017-10-04
Abstract: The present invention is directed to methods for treating diarrhea, both chronic or acute forms, by the administration of a therapeutically or prophylactically effective amount of antibodies and fragments thereof having binding specificity for CGRP. In particular the methods prevent or reduce diarrhea in conditions or treatments resulting in elevated CGRP levels, e.g., in the GI tract (colon) that are associated with diarrhea and/or improper electrolyte and fluid excretion from the bowel or urinary system. More specifically, this invention relates to treatments using the anti-CGRP antibodies and fragments described herein, and binding fragments thereof.
Patent AU-2017278398-A1 (AU)
Title: Hydration control mixture for mortar and cement compositions
Inventor: DENGLER JOACHIM
IPC: C04B111/28
Filed: 2017-06-09
Abstract: The present invention relates to a mixture comprising at least one compound comprising an α-hydroxy-carboxylic unit, α-hydroxy-sulfonic acid unitor α-carbonyl-carboxylic unit and at least one water-soluble organic carbonate. The mixture is useful as a hydration control agent in construction chemical compositions comprising an inorganic binder.
Patent AU-2017279825-A1 (AU)
Title: Planetary wheel drive brake
Inventor: MARTIN SCOTT
IPC: F16H3/00
Filed: 2017-10-23
Abstract: A planetary wheel drive uses a brake having a stamped spring plate which includes a plurality of spring stabilizer connections. Each one of the plurality of springs is mechanically bonded to a respective one of the plurality of spring stabilizer connections. A brake piston includes a bore therethrough and resides in sliding engagement with the stationary spindle. The brake piston is generally cylindrically shaped with an inner portion and an outer portion. The plurality of coil springs reside between said spring stabilizers and said inner shoulder of said brake piston. Pressurized hydraulic fluid releases the brake.
Patent AU-2017311252-A1 (AU)
Title: Locking mechanism for an energy module
Inventor: BONA GERHARD
IPC: H02B1/36
Filed: 2017-07-05
Abstract: The invention relates to a locking mechanism (7) for an energy module (4) on a coupling insert (1), wherein the coupling insert (1) functions to receive at least one insert (3), comprising a guide element (8) and a locking element (9), wherein the guide element (8) and the locking element (9) can be secured to the coupling insert (1), and wherein the guide element (8) has a first opening (15) through which an operating key can be guided in order to actuate the energy module (4), and wherein the locking element (9) has a blocking bolt (17) which engages into the first opening (15) of the guide element (8) in the use position of the locking mechanism (7), and blocks same in terms of the guiding through of the operating key, wherein the locking element (9) is arranged on the coupling insert (1), in the use position, in such a way that a release of the first opening (15) is only possible by removing the locking element (9) when there is no insert (3) in the coupling insert (1).
Patent AU-2017328310-A1 (AU)
Title: Antibody specifically binding to IL-17A and functional fragment thereof
Inventor: SONG NANMENG
IPC: A61P37/02
Filed: 2017-09-08
Abstract: An antibody specifically binding to IL-17A and a functional fragment thereof. The antibody or functional fragment thereof includes an IL-17A chimeric antibody and a functional fragment thereof, and an IL-17A humanized antibody and a functional fragment thereof.
Patent AU-2017336412-A1 (AU)
Title: Neonatal drape device
Inventor: CARRASCO NOEL J M
IPC: A61B46/20
Filed: 2017-09-26
Abstract: A neonatal drape device for protecting a neonatal subject comprising a sheet configured to receive the neonatal subject in a supine position. The sheet has a base, at least one side edge, and a plurality of separation lines. The separation lines extend inwardly from the at least one side edge of the sheet. The sheet is sufficiently pliable so as to wrap and conform to the neonatal subject. The sheet further includes a plurality of notches disposed adjacent to the base, each at an inner end of one of the separation lines. The notches are configured to allow a cable to extend from an internal space of the neonatal drape device to an external location while the sheet is wrapped around the neonatal subject.